All Stories

  1. Comparative Effects of Efavirenz and Dolutegravir on Metabolomic and Inflammatory Profiles, and Platelet Activation of People Living with HIV: A Pilot Study

    Article • Viruses, September 2024, MDPI AG

    Prof Helen Carolyn Steel, Prof Jan Gert Nel

  2. Oral Presentation of Haematological Disease: Part II – Iron Deficiency Anaemia

    Article • South African Dental Journal, September 2024, Academy of Science of South Africa

    Prof Jan Gert Nel

  3. Oral Presentation of Haematological Disease: Part I – Diseases of Bone Marrow Failure

    Article • South African Dental Journal, July 2024, Academy of Science of South Africa

    Prof Jan Gert Nel

  4. Race in health research: Considerations for researchers and research ethics committees

    Article • South African Journal of Bioethics and Law, May 2023, Health and Medical Publishing Group

    Prof Jan Gert Nel

  5. Dolutegravir potentiates platelet activation by a calcium-dependent, ionophore-like mechanism

    Article • Journal of Immunotoxicology, November 2022, Taylor & Francis

    Prof Pieter Meyer, Prof Jan Gert Nel

  6. ADP-Mediated Upregulation of Expression of CD62P on Human Platelets Is Critically Dependent on Co-Activation of P2Y1 and P2Y12 Receptors

    Article • Pharmaceuticals, November 2020, MDPI AG

    Prof Helen Carolyn Steel, Prof Jan Gert Nel

  7. HIV and haematopoiesis

    Article • South African Medical Journal, September 2019, Health and Medical Publishing Group

    Prof Jan Gert Nel

  8. Clofazimine, but Not Isoniazid or Rifampicin, Augments Platelet Activation in vitro

    Article • Frontiers in Pharmacology, November 2018, Frontiers

    Prof Jan Gert Nel

  9. Dilute Russel Viper Venom Time analysis in a Haematology Laboratory: An audit

    Article • International Journal of Laboratory Hematology, April 2018, Wiley

    Welma Kruger, Prof Pieter Meyer, Prof Jan Gert Nel

  10. Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia

    Article • International Journal of Molecular Sciences, April 2018, MDPI AG

    Prof Jan Gert Nel

  11. Pneumolysin mediates neutrophil:platelet aggregation via a P-selectin- and protease-activated receptor-1 (PAR-1)-dependent mechanism

    Article • September 2017, European Respiratory Society (ERS)

    Prof Jan Gert Nel

  12. Pneumolysin mediates heterotypic aggregation of neutrophils and platelets in vitro

    Article • Journal of Infection, June 2017, Elsevier

    Prof Jan Gert Nel

  13. S47 Pneumolysin promotes neutrophil: platelet aggregation in vitro

    Article • Thorax, November 2016, BMJ

    Prof Jan Gert Nel

  14. Pneumolysin Mediates Platelet Activation In Vitro

    Article • Lung, May 2016, Springer Science + Business Media

    Prof Jan Gert Nel

  15. Pneumolysin and neutrophil extracellular traps

    Article • Clinical & Experimental Immunology, March 2016, Wiley

    Prof Jan Gert Nel, Professor Timothy Mitchell

  16. Neutrophil extracellular traps and their role in health and disease

    Article • South African Journal of Science, January 2016, Academy of Science of South Africa

    Prof Jan Gert Nel

  17. S85 Pneumolysin triggers the production of platelet-activating factor by human neutrophils in vitro: Abstract S85 Table 1

    Article • Thorax, November 2015, BMJ

    Prof Jan Gert Nel

  18. Induction of neutrophil extracellular traps (NETs) by the pneumococcal toxin, pneumolysin (Ply)

    Article • September 2015, European Respiratory Society (ERS)

    Prof Jan Gert Nel